Last reviewed · How we verify
dihydroartemisinin-piperaquine plus azithromycin
dihydroartemisinin-piperaquine plus azithromycin is a Small molecule drug developed by Liverpool School of Tropical Medicine. It is currently in Phase 3 development. Also known as: Eurartesim plus Zithromax.
At a glance
| Generic name | dihydroartemisinin-piperaquine plus azithromycin |
|---|---|
| Also known as | Eurartesim plus Zithromax |
| Sponsor | Liverpool School of Tropical Medicine |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa (PHASE3)
- Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dihydroartemisinin-piperaquine plus azithromycin CI brief — competitive landscape report
- dihydroartemisinin-piperaquine plus azithromycin updates RSS · CI watch RSS
- Liverpool School of Tropical Medicine portfolio CI
Frequently asked questions about dihydroartemisinin-piperaquine plus azithromycin
What is dihydroartemisinin-piperaquine plus azithromycin?
dihydroartemisinin-piperaquine plus azithromycin is a Small molecule drug developed by Liverpool School of Tropical Medicine.
Who makes dihydroartemisinin-piperaquine plus azithromycin?
dihydroartemisinin-piperaquine plus azithromycin is developed by Liverpool School of Tropical Medicine (see full Liverpool School of Tropical Medicine pipeline at /company/liverpool-school-of-tropical-medicine).
Is dihydroartemisinin-piperaquine plus azithromycin also known as anything else?
dihydroartemisinin-piperaquine plus azithromycin is also known as Eurartesim plus Zithromax.
What development phase is dihydroartemisinin-piperaquine plus azithromycin in?
dihydroartemisinin-piperaquine plus azithromycin is in Phase 3.
Related
- Manufacturer: Liverpool School of Tropical Medicine — full pipeline
- Also known as: Eurartesim plus Zithromax
- Compare: dihydroartemisinin-piperaquine plus azithromycin vs similar drugs
- Pricing: dihydroartemisinin-piperaquine plus azithromycin cost, discount & access